DOI: 10.2337/diacare.29.02.06.dc05-1770 © 2006 by the American Diabetes Association © 2006 by the American Diabetes Association, Inc.
Autologous Transplantation of Granulocyte ColonyStimulating FactorMobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in DiabetesResponse to Huang et al.Department of Clinical and Experimental Medicine, Metabolic Division, University of Padova Medical School, Padova, Italy Address correspondence to Gian Paolo Fadini, MD, Dipartimento di Medicina Clinica e Sperimentale, Divisione di Malattie del Metabolismo, Policlinico Universitario, Via Giustiniani, 2, 35100 Padova, Italy. E-mail: gianpaolofadini@hotmail.com
Huang et al. (1), in their small seminal clinical trial of cellular therapy for critical limb ischemia in diabetic patients, did not include presence of diabetic retinopathy among their exclusion criteria. It is known that individuals with diabetes are subjected to poor blood vessel growth in ischemic hearts and limbs and increased angiogenesis in retinal complications. This so-called "diabetic paradox" has been attributed
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||